Complete Response to Definitive Radiotherapy With Concurrent Systemic Therapy for Locally Advanced Head and Neck Cancer: Associated Factors and Impact on Outcomes

被引：0
|
作者：
Dragovic, Aleksandar F. [1 ]
Caudell, Jimmy J. [2 ]
Bonner, James A. [1 ]
机构：
[1] Univ Alabama, Birmingham, AL USA
[2] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA
来源：
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2011年 / 34卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
32
引用
收藏
页码：210 / 210
页数：1
相关论文
共 50 条
  • [21] Prolongation of definitive head and neck cancer radiotherapy: Survival impact and predisposing factors
    Xiang, Michael
    Gensheimer, Michael F.
    Pollom, Erqi L.
    Holsinger, Floyd Christopher
    Colevas, Alexander D.
    Quynh-Thu Le
    Beadle, Beth M.
    RADIOTHERAPY AND ONCOLOGY, 2021, 156 : 201 - 208
  • [22] Decreased overall survival in patients with locally advanced head and neck cancer receiving definitive radiotherapy and concurrent cetuximab: National Cancer Database analysis
    Korpics, Mark C.
    Turchan, William Tyler
    Koshy, Matthew
    Spiotto, Michael T.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2022, 44 (07): : 1528 - 1544
  • [23] Concurrent cisplatin and radiotherapy in advanced head and neck cancer
    Rehan Asif
    Kamlesh Chandra
    Vanita Chopra
    M. L. B. Bhatt
    Indian Journal of Otolaryngology and Head and Neck Surgery, 2003, 55 (2): : 94 - 96
  • [24] Impact of hypofractionated schemes in radiotherapy for locally advanced head and neck cancer patients
    Franzese, Ciro
    Fogliata, Antonella
    Franceschini, Davide
    Navarria, Pierina
    Cozzi, Luca
    Tomatis, Stefano
    De Virgilio, Armando
    Spriano, Giuseppe
    Scorsetti, Marta
    LARYNGOSCOPE, 2020, 130 (04): : E163 - E170
  • [25] Induction chemotherapy followed by hyperfractionated radiotherapy with concurrent chemotherapy for locally advanced head and neck cancer
    Karasawa, K
    Shinoda, H
    Katsui, K
    Seki, K
    Kohno, M
    Hanyu, N
    Nasu, S
    Muramatsu, H
    Maebayashi, K
    Mitsuhashi, N
    Yoshihara, T
    ANTICANCER RESEARCH, 2003, 23 (6D) : 5031 - 5036
  • [26] Manageable Early Toxicity of Cetuximab Concurrent with Radical Radiotherapy for Locally Advanced Head and Neck Cancer
    Wieczorek, A.
    Hamid, A.
    O'Toole, L.
    CLINICAL ONCOLOGY, 2011, 23 (07) : 496 - 496
  • [27] Phase I study of concurrent capecitabine and paclitaxel with radiotherapy in locally advanced head and neck cancer
    Kanani, S
    Suntharalingam, M
    Wolf, J
    Duckham, E
    Gray, WC
    Ord, RA
    RADIOLOGY, 2002, 225 : 506 - 507
  • [28] Definitive radiotherapy in oligometastatic head and neck cancers responding to systemic therapy
    Tandon, S.
    Gairola, M.
    Ahlawat, P.
    Narang, R.
    Varghese, A.
    Sharma, M.
    RADIOTHERAPY AND ONCOLOGY, 2019, 141 : S55 - S55
  • [29] Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy
    Davide Franceschini
    Fabiola Paiar
    Calogero Saieva
    Pierluigi Bonomo
    Benedetta Agresti
    Icro Meattini
    Daniela Greto
    Monica Mangoni
    Fiammetta Meacci
    Mauro Loi
    Giacomo Zei
    Lorenzo Livi
    Giampaolo Biti
    La radiologia medica, 2016, 121 : 229 - 237
  • [30] Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy
    Franceschini, Davide
    Paiar, Fabiola
    Saieva, Calogero
    Bonomo, Pierluigi
    Agresti, Benedetta
    Meattini, Icro
    Greto, Daniela
    Mangoni, Monica
    Meacci, Fiammetta
    Loi, Mauro
    Zei, Giacomo
    Livi, Lorenzo
    Biti, Giampaolo
    RADIOLOGIA MEDICA, 2016, 121 (03): : 229 - 237
12345